The Eighth Circuit Court of Appeals recently ruled on a significant case involving the regulation of electronic nicotine delivery systems (ENDS) in Iowa. The court vacated a preliminary injunction that had previously blocked enforcement of a state law, House File 2677 (HF 2677), which restricts the sale of e-cigarettes that lack federal approval. This decision affects e-cigarette manufacturers, retailers, and consumers in Iowa, highlighting the ongoing debate over state versus federal authority in regulating tobacco products.

The case, Iowans for Alternatives v. Mary Mosiman, was filed after HF 2677 was enacted by the Iowa legislature in 2024. The law prohibits the manufacture and sale of e-cigarettes that have not received marketing authorization from the U.S. Food and Drug Administration (FDA). A coalition of e-cigarette manufacturers, retailers, and consumers, collectively known as Iowans for Alternatives, challenged the law, claiming it was preempted by federal law. They sought a preliminary injunction to halt the law's enforcement, which the district court granted, stating that the plaintiffs were likely to succeed on their preemption claim.

Mary Mosiman, the Director of the Iowa Department of Revenue, appealed the district court's decision. The Eighth Circuit Court, which includes judges Loken, Gruender, and Grasz, reviewed the case and ultimately disagreed with the lower court's ruling. The judges found that while Iowans for Alternatives had standing to bring the case, they were not likely to prevail on the merits of their preemption claim.

The court's ruling centered around the interpretation of HF 2677 and its relationship to federal law. The judges noted that the law requires e-cigarette manufacturers to certify compliance with the FDA's premarket authorization process, which the plaintiffs argued conflicted with federal law. However, the court concluded that HF 2677 does not impose an obstacle to the objectives of the federal Tobacco Control Act (TCA) and is not preempted by federal law.

The court stated, "HF 2677 is not preempted... [it] does not require ENDS product manufacturers or retailers to deviate from federal law."

The judges emphasized that states retain the authority to regulate public health and safety, particularly concerning tobacco products. They pointed out that HF 2677 is consistent with the TCA's goals of ensuring that tobacco products meet safety standards before being sold to consumers. The court also highlighted that the law's additional requirements, such as certification and fees, do not conflict with federal regulations.

This ruling has significant implications for the future of e-cigarette regulation in Iowa. By vacating the preliminary injunction, the Eighth Circuit allows the state law to take effect, which means that e-cigarette manufacturers and retailers in Iowa must comply with HF 2677 to avoid penalties. This decision reinforces the state's ability to impose stricter regulations on tobacco products, even in the face of federal laws.

The Eighth Circuit's ruling also sets a precedent for similar cases involving state regulation of tobacco products. It clarifies that states can enact laws that may be more stringent than federal regulations as long as they do not conflict with federal objectives. This could encourage other states to pursue similar regulatory measures in the future.

Looking ahead, the decision may be appealed to the U.S. Supreme Court, although it is unclear if the plaintiffs will pursue that option. There may also be related cases pending in other jurisdictions as the legal landscape surrounding e-cigarette regulation continues to evolve. The outcome of this case could influence how states approach the regulation of vaping products and their compliance with federal law.

In conclusion, the Eighth Circuit's ruling in Iowans for Alternatives v. Mary Mosiman marks a significant development in the ongoing debate over the regulation of e-cigarettes. The decision allows Iowa to enforce its law aimed at ensuring the safety of tobacco products, while also reaffirming the state's authority to regulate public health matters.